These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26457409)

  • 1. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies.
    Tsuboi H; Sumida T; Noma H; Yamagishi K; Anami A; Fukushima K; Horigome H; Maeno Y; Kishimoto M; Takasaki Y; Nakayama M; Waguri M; Sago H; Murashima A
    Mod Rheumatol; 2016 Jul; 26(4):569-75. PubMed ID: 26457409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block.
    Anami A; Fukushima K; Takasaki Y; Sumida T; Waguri M; Wake N; Murashima A
    Mod Rheumatol; 2013 Jul; 23(4):653-8. PubMed ID: 22760476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
    Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
    J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fetal complete heart block with myocarditis and maternal SS-A-/AA-B/antibodies].
    Lang B; Wilhelm C; Gildein P; Vaith P; Schillinger H; Peter HH
    Schweiz Med Wochenschr; 1990 Nov; 120(46):1741-4. PubMed ID: 2251494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
    Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile.
    Meilof JF; Frohn-Mulder IM; Stewart PA; Szatmari A; Hess J; Veldhoven CH; Smeenk RJ; Swaak AJ
    Lupus; 1993 Aug; 2(4):239-46. PubMed ID: 7505695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of maternal autoimmune response to clinical manifestations in children with congenital complete heart block.
    Eronen M; Miettinen A; Walle TK; Chan EK; Julkunen H
    Acta Paediatr; 2004 Jun; 93(6):803-9. PubMed ID: 15244231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
    J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal lupus erythematosus in Japan: a review of the literature.
    Kobayashi R; Mii S; Nakano T; Harada H; Eto H
    Autoimmun Rev; 2009 May; 8(6):462-6. PubMed ID: 19162245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
    Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
    Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two case reports of neonatal autoantibody-associated congenital heart block.
    Li X; Huang X; Lu H
    Medicine (Baltimore); 2018 Nov; 97(45):e13185. PubMed ID: 30407356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
    Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
    Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of mothers of children with complete congenital heart block.
    Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
    Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Julkunen H; Siren MK; Kaaja R; Kurki P; Friman C; Koskimies S
    Br J Rheumatol; 1995 Oct; 34(10):901-7. PubMed ID: 7582692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal congenital heart block.
    Yildirim A; Tunaoolu FS; Karaaoac AT
    Indian Pediatr; 2013 May; 50(5):483-8. PubMed ID: 23778728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
    Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
    Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
    Friedman DM; Rupel A; Glickstein J; Buyon JP
    Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serologic marker for fetal risk of congenital heart block.
    Salomonsson S; Dörner T; Theander E; Bremme K; Larsson P; Wahren-Herlenius M
    Arthritis Rheum; 2002 May; 46(5):1233-41. PubMed ID: 12115229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.